id | C00031129 |
---|---|
Name | RA V |
CAS RN | 64725-24-2 |
Standard InChI | InChI=1S/C40H48N6O9/c1-22-35(48)42-23(2)38(51)44(4)30(18-25-8-13-28(54-7)14-9-25)37(50)43-24(3)39(52)46(6)32-19-26-10-15-29(16-11-26)55-34-21-27(12-17-33(34)47)20-31(36(49)41-22)45(5)40(32)53/h8-17,21-24,30-32,47H,18-20H2,1-7H3,(H,41,49)(H,42,48)(H,43,50)/t22-,23+,24+,30+,31+,32+/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C40H48N6O9/c1-22-35(48)42-23(2)38(51)44(4)30(18-25-8-13-28(54-7)14-9-25)37(50)43-24(3)39(52)46(6)32-19-26-10-15-29(16-11-26)55-34-21-27(12-17-33(34)47)20-31(36(49)41-22)45(5)40(32)53/h8-17,21-24,30-32,47H,18-20H2,1-7H3,(H,41,49)(H,42,48)(H,43,50) |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 497 |
By standard InChI | CHEMBL404613 |
---|---|
By standard InChI Main Layer | CHEMBL319656 CHEMBL404613 CHEMBL1475206 CHEMBL1705256 CHEMBL2361311 |
By LinkDB |
---|
By CAS RN | C043547 |
---|
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Rubia akane | 25473 | Rubiaceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL1475206 |
CHEMBL1741321
(1)
|
1 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL1475206 |
CHEMBL1613842
(1)
|
4 / 2 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL1705256 |
CHEMBL2114784
(1)
|
1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1475206 |
CHEMBL1741325
(1)
|
0 / 1 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL1475206 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL1705256 |
CHEMBL2114843
(1)
CHEMBL2114780
(1)
|
0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL1705256 |
CHEMBL2114788
(1)
|
0 / 0 |
P42226 | Signal transducer and activator of transcription 6 | Unclassified protein | CHEMBL1475206 |
CHEMBL1614338
(1)
CHEMBL1614070
(1)
|
0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL1475206 |
CHEMBL1741322
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1475206 |
CHEMBL1741323
(1)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1475206 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
CHEMBL1741324 (1) |
0 / 1 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL1705256 |
CHEMBL1794483
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL1705256 |
CHEMBL1738184
(1)
|
0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL1705256 |
CHEMBL2354311
(1)
|
1 / 0 |
P01215 | Glycoprotein hormones alpha chain | Unclassified protein | CHEMBL1705256 |
CHEMBL2114913
(1)
|
0 / 3 |
Q06710 | Paired box protein Pax-8 | Unclassified protein | CHEMBL1705256 |
CHEMBL2354215
(1)
CHEMBL2354301
(1)
|
1 / 2 |
OMIM | preferred title | UniProt |
---|---|---|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#218700 | Hypothyroidism, congenital, nongoitrous, 2; chng2 |
Q06710
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
KEGG | disease name | UniProt |
---|---|---|
H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
H00082 | Graves' disease |
P01215
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
Q06710 (related) |
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00032 | Thyroid cancer |
Q06710
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|